Ep. 65: "Most Drugs Are Bad for You" - Robin Hanson & Sebastian Brunemeier Return, The Crisis of Health Outcomes, Sclerosis of Science and Special Jurisdictions as Solutions

Two of the most popular previous guests are back: Sebastian Brunemeier, the General Partner of Healthspan Capital and CEO of ImmuneAGE Pharma, and Robin Hanson, Professor of Economics at George Mason University and iconic thinker.Sebastian previously talked about longevity biotech and decentralized science. Robin spoke about prediction markets and governance innovation.In this episode, we talk about the surprising science of health outcomes. Equipped with vast amounts of money and talent (18% of GDP), the healthcare market disappoints egregiously when it comes to making us living longer and healthy.Robin explains why that is: it's hidden motives in human behavior. We defer rational decision-making to authorities with the incentive to overmedicate us.Increased spending and more drugs make us worse.Sebastian can confirm as a practicing scientist how the pharma-industrial complex and regulatory monopoly are drivers of a massive misallocation of capital.However, we have now learned much about the potential of special jurisdictions, medical tourism, and regulatory flexibility.Niklas and Sebastian have worked together over the past year to implement some groundbreaking ideas in practice: life insurance coupled with healthcare, for example, is an idea that is waiting for the right jurisdiction to make it possible.At the following events, we'll gather renegade life scientists, biotechnology engineers, and crypto hackers to build the healthcare system of the future:Nov 3-5: Crypto Futures & Legal Engineering 2023 - A Próspera Builders' Summit https://lu.ma/crypto_legal2023Nov 17-19: DeSci & Longevity Biotech 2023 - A Próspera Builders' Summit https://lu.ma/longevity2023There is a unique event that we're currently collecting a waitlist for:Jan 6 - Mar 1: Vitalia - Starting the Frontier City of Life https://lu.ma/vitalia